Clinical Trial Update: The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety, tolerability, and pharmacokinetics of SYH9017 in Chinese participants with overweight or obesity. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• SYH9017

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Overweight or Obesity | Phase 1 | Status: RECRUITING